Poster Session 2
Category: Ultrasound/Imaging
Poster Session 2
Xiteng Yan, MD (he/him/his)
Maternal Fetal Medicine Fellow
Icahn School of Medicine, Mount Sinai West
New York, New York, United States
Johanna A. Suskin, MD (she/her/hers)
Ob/Gyn Resident Physician
Icahn School of Medicine, Mount Sinai West
New York, New York, United States
Isaiah Smolar, MD
Icahn School of Medicine, Mount Sinai West
New York, New York, United States
Thomas Owens, MD
Maternal Fetal Medicine Physician
Icahn School of Medicine at Mount Sinai
Atlanta, Georgia, United States
Mia Heiligenstein, MD
Icahn School of Medicine, Mount Sinai West
New York City, New York, United States
Shelly Thai, MD
Icahn School of Medicine, Mount Sinai West
New York, New York, United States
Ceyda Oner, MD
Fellow
Division of Maternal-Fetal Medicine, Icahn School of Medicine at Mount Sinai West
New York, New York, United States
Jo Hsuan Lee, MS
Biostatistician
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai, New York, United States
Guillaume Stoffels
Icahn School of Medicine at Mount Sinai
New York, New York, United States
Lois Brustman, MD
Icahn School of Medicine, Mount Sinai West
New York, New York, United States
Zainab Al-Ibraheemi, MD
Mount Sinai West
New York City, New York, United States
An increased nuchal translucency (NT) is a well-known marker for genetic and structural anomalies. Increased NT is typically defined either as a measurement > 3mm or by values > 95th percentile. However, there is limited data on the significance of NT > 95th percentile but < 3mm. We hypothesize that using the 95th percentile as a threshold for evaluation may enhance detection of anomalies in pregnancies with normal non-invasive prenatal testing (NIPT).
Study Design:
This retrospective study included patients who received prenatal ultrasounds at a large, academic center between 2018 and 2023. Participants with an NT< 3mm, normal NIPT and a completed early or comprehensive anatomy ultrasound were included. Patients were divided into two groups- increased (>95th percentile) vs normal (< 95th percentile) NT. Other data collected included invasive genetic testing, fetal echocardiography, and perinatal outcomes. Analysis was performed via Student’s t-test, Mann Whitney’s U test, Chi square or Fisher’s Exact test.
Results:
A total of 176 cases were included: 58 (33.0%) had an increased NT and 118 (67.0%) had a normal NT. Results are in Table 1. Although odds of detecting anomalies were 78% higher with an increased NT, this was not significant (OR 1.78, 95% CI 0.54–5.84). No association was seen between an increased NT and anomaly detection on either early (p=0.82) or full anatomy (p=0.53). Patients with increased NT were more likely to get invasive genetic testing (p=0.0004) and fetal echocardiograms (p=< 0.0001). Increased testing did not improve detection of genetic (p=1.00) or cardiac (p=1.00) anomalies. Of note, patients with increased NT were more likely to be Asian/Pacific Islander or White (p< 0.0001) and have a male fetus (p=0.011).
Conclusion:
In patients with normal NIPT, an increased NT >95th percentile but < 3mm was not linked to a higher rate of anomaly detection. Patients were more likely to pursue additional testing despite similar outcomes. Thus, an increased NT >95th percentile but < 3mm may have limited clinical utility and could contribute to unnecessary testing and patient anxiety.